Literature DB >> 3141456

Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains.

D Grothues1, U Koopmann, H von der Hardt, B Tümmler.   

Abstract

The epidemiology of Pseudomonas aeruginosa infection at a cystic fibrosis (CF) center was monitored over a 3-year period. A total of 835 isolates from 72 unrelated patients and 22 siblings with CF were analyzed by genome fingerprinting and serotyping, bacteriophage typing, and pyocin typing. For genome fingerprinting, bacterial chromosomes were digested with one of the restriction endonucleases SpeI, DraI, XbaI, SspI, and NheI, which cut only rarely, and subsequently separated by field inversion gel electrophoresis. The physical genome analysis allowed us to classify P. aeruginosa strains in terms of DNA relatedness. Related strains differed by fewer than six DraI bands in the fingerprint, whereas unrelated strains differed by more than 20 DraI bands. All unrelated CF patients were colonized with different strains. The absence of a nosocomial spread of organisms at the CF center was attributed to the strict hygiene measures observed at the hospital. CF siblings were harboring either identical or closely related strains; transmission within the family is thought to be the most likely cause.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3141456      PMCID: PMC266800          DOI: 10.1128/jcm.26.10.1973-1977.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

Review 1.  Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction.

Authors:  G B Pier
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

2.  Serogroups of Pseudomonas aeruginosa and the immune response of patients with cystic fibrosis.

Authors:  E Diaz; L L Mosovich; E Neter
Journal:  J Infect Dis       Date:  1970-03       Impact factor: 5.226

3.  Serotypes and antibiotic susceptibilities of Pseudomonas aeruginosa isolates from single sputa of cystic fibrosis patients.

Authors:  T W Seale; H Thirkill; M Tarpay; M Flux; O M Rennert
Journal:  J Clin Microbiol       Date:  1979-01       Impact factor: 5.948

4.  Multiple of isolates of Pseudomonas aeruginosa with differing antimicrobial susceptibility patterns from patients with cystic fibrosis.

Authors:  M J Thomassen; C A Demko; B Boxerbaum; R C Stern; P J Kuchenbrod
Journal:  J Infect Dis       Date:  1979-12       Impact factor: 5.226

5.  Revised pyocin typing method for Pseudomonas aeruginosa.

Authors:  J A Fyfe; G Harris; J R Govan
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

6.  Does pseudomonas cross-infection occur between cystic-fibrosis patients.

Authors:  N M Kelly; M X Fitzgerald; E Tempany; C O'Boyle; F R Falkiner; C T Keane
Journal:  Lancet       Date:  1982-09-25       Impact factor: 79.321

7.  Epidemiology of Pseudomonas aeruginosa infection in patients treated at a cystic fibrosis centre.

Authors:  N Høiby; K Rosendal
Journal:  Acta Pathol Microbiol Scand B       Date:  1980-06

8.  Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains.

Authors:  R E Hancock; L M Mutharia; L Chan; R P Darveau; D P Speert; G B Pier
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

9.  The relationship of phenotype changes in Pseudomonas aeruginosa to the clinical condition of patients with cystic fibrosis.

Authors:  A Penketh; T Pitt; D Roberts; M E Hodson; J C Batten
Journal:  Am Rev Respir Dis       Date:  1983-05

10.  Characterization and use of a DNA probe as an epidemiological marker for Pseudomonas aeruginosa.

Authors:  J W Ogle; J M Janda; D E Woods; M L Vasil
Journal:  J Infect Dis       Date:  1987-01       Impact factor: 7.759

View more
  73 in total

1.  DNA banding pattern polymorphism in vancomycin-resistant Enterococcus faecium and criteria for defining strains.

Authors:  D Morrison; N Woodford; S P Barrett; P Sisson; B D Cookson
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

Review 2.  Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex.

Authors:  J R Govan
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

3.  Rapid pulsed-field gel electrophoresis method for group B streptococcus isolates.

Authors:  J A Benson; P Ferrieri
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

4.  Genome fingerprinting by pulsed-field gel electrophoresis and ribotyping to differentiate Pseudomonas aeruginosa serotype O11 strains.

Authors:  C L Poh; C C Yeo; L Tay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-09       Impact factor: 3.267

Review 5.  Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandoraea spp.

Authors:  Andrew M Jones; A Kevin Webb
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

6.  Genotypic diversity of Pseudomonas aeruginosa in cystic fibrosis siblings in Qatar using AFLP fingerprinting.

Authors:  A Abdul Wahab; S J Taj-Aldeen; F Hagen; S Diophode; A Saadoon; J F Meis; C H Klaassen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-01       Impact factor: 3.267

7.  A major Pseudomonas aeruginosa clone common to patients and aquatic habitats.

Authors:  U Römling; J Wingender; H Müller; B Tümmler
Journal:  Appl Environ Microbiol       Date:  1994-06       Impact factor: 4.792

8.  Field inversion gel electrophoresis on Pseudomonas cepacia strains isolated from cystic fibrosis patients.

Authors:  G Amalfitano; E Tonolli; F Favari; C Perazzoli; G Cazzola; G Mastella; I Piacentini
Journal:  Eur J Epidemiol       Date:  1996-04       Impact factor: 8.082

9.  Risk of cross-colonization and infection by Pseudomonas aeruginosa in a holiday camp for cystic fibrosis patients.

Authors:  J A Hoogkamp-Korstanje; J F Meis; J Kissing; J van der Laag; W J Melchers
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

10.  Discriminatory power of three DNA-based typing techniques for Pseudomonas aeruginosa.

Authors:  H Grundmann; C Schneider; D Hartung; F D Daschner; T L Pitt
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.